Immunoneutralization of follicle stimulating hormone does not affect gonadotrophin surge-inhibiting factor/attenuating factor bioactivity during the rat ovarian cycle

By Tio S   van Dieten JAMJ   de Koning J  

Human Reproduction, Vol. 13, Iss. 10, 1998-10 ,pp. : 2731-2737

Oxford University Press

Access to resources Recommend Favorite

Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role

By Dafopoulos K.  

Human Reproduction, Vol. 19, Iss. 9, 2004-09 ,pp. : 1985-1992

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Purification of a candidate gonadotrophin surge attenuating factor from human follicular fluid

By Pappa Aglaia  

Human Reproduction, Vol. 14, Iss. 6, 1999-06 ,pp. : 1449-1456

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Comparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundability

By Teissier M.P.  

Human Reproduction, Vol. 15, Iss. 12, 2000-12 ,pp. : 2471-2477

Oxford University Press

Access to resources Recommend Favorite

Reproductive endocrinology. Follicular fluid concentration of leukaemia inhibitory factor is decreased among women with polycystic ovarian syndrome during assisted reproduction cycles

By Lédée-Bataille N.  

Human Reproduction, Vol. 16, Iss. 10, 2001-10 ,pp. : 2073-2078

Oxford University Press

Access to resources Recommend Favorite